Non-Viral ssDNA Vector Delivery Strategies to Optimize Persistence & Patient Safety

By | 21 April 2026
  • In vivo immune cell engineering with ssDNA
  • Developing strategies to allow long term persistence and gene expression
  • Preclinical evidence and scale up